INTERNATIONAL REMOTE IMAGING SYSTEMS INC /DE/
8-K, 1999-10-15
LABORATORY ANALYTICAL INSTRUMENTS
Previous: KLA TENCOR CORP, DEF 14A, 1999-10-15
Next: INTERNATIONAL REMOTE IMAGING SYSTEMS INC /DE/, 8-K, 1999-10-15



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934



        Date of report (Date of earliest event reported): October 7, 1999


                   INTERNATIONAL REMOTE IMAGING SYSTEMS, INC.
               (Exact Name of Registrant as Specified in Charter)


         DELAWARE                         1-9767                  94-2579751
(State or Other Jurisdiction           (Commission              (IRS Employer
     of Incorporation)                 File Number)          Identification No.)


9162 ETON AVENUE, CHATSWORTH, CALIFORNIA                           91311
(Address of Principal Executive Offices)                         (Zip Code)


       Registrant's telephone number, including area code: (818) 709-1244


<PAGE>   2


Item 5.  Other Events.

         On October 7, 1999, the Registrant issued a press release announcing
that the Thermo Amex Convertible Growth Fund ("Thermo Amex") converted its $3
million investment in 3,000 shares of the Registrant's Series A Convertible
Preferred Stock into 2 million shares of the Registrant's common stock at a
conversion price of $1.50 per share of common stock..

         A copy of the press release is attached as Exhibit 99 hereto and
incorporated herein by reference.


                                        2
<PAGE>   3


                                   SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                              INTERNATIONAL REMOTE IMAGING
                                                SYSTEMS, INC.



Dated:  October 15, 1999                      By: /s/ MARTIN S. McDERMUT
                                                 -------------------------------
                                                 Martin S. McDermut
                                                 Vice President - Finance and
                                                 Administration, Chief Financial
                                                 Officer and Secretary


                                       3
<PAGE>   4



                                  Exhibit Index

No.          Document
- ---          --------

99           Press Release dated October 7, 1999


                                       4

<PAGE>   1




[IRIS GRAPHIC]                                                      NEWS RELEASE
- --------------------------------------------------------------------------------
CONTACTS:   MARTIN S. MCDERMUT, VICE PRESIDENT AND CFO
            818-709-1244 OR
            ROBERT FROST, ECOM CONSULTANTS
            212-391-9475                                   FOR IMMEDIATE RELEASE
- --------------------------------------------------------------------------------


                        THERMO AMEX CONVERTS $3 MILLION

                      OF IRIS PREFERRED SHARES INTO COMMON


         CHATSWORTH, CA, October 7, 1999 -- International Remote Imaging
Systems, Inc. (IRI-ASE), a leading manufacturer and marketer of automated in
vitro diagnostic (IVD) imaging systems, reported today that the Thermo Amex
Convertible Growth Fund has converted its $3 million investment in the 3,000
shares of the company's Series A Convertible Preferred Stock into 2 million
shares of common stock. As a result of the conversion the Company now has
9,172,607 shares of common stock outstanding. As previously disclosed in
Company's SEC filings, Thermo Amex had the right since 1997 to convert its
investment into the company's common shares at a discount to market, subject to
a maximum of two million common shares.

         IRIS designs, develops, manufactures and markets IVD imaging systems
based on its patented and proprietary AIM technology for automating microscopic
procedures performed in hospital and reference clinical laboratories and
genetics laboratories, worldwide. Its major product lines are The Yellow IRIS(R)
family of urinalysis workstations, the PowerGene(TM) line of cytogenetic
analyzers and the StatSpin line of centrifugal specimen preparation devices.


                                   * * * * * *


                                       5


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission